Circular Genomics

About:

Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostics for neurological diseases.

Website: https://www.circulargenomics.com/

Twitter/X: circgenomics

Top Investors: UNM Rainforest Innovations, New Mexico Economic Development Department, Tramway Venture Partners, Mountain Group Capital, Cottonwood Technology Fund

Description:

Circular Genomics is the global leader in the use of circular RNA as a novel biomarker to power precision medicine to improve the diagnosis and treatment of neurological and psychiatric conditions. The company was founded in 2021 and is headquartered in Albuquerque, New Mexico.

Total Funding Amount:

$12.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Albuquerque, New Mexico, United States

Founded Date:

2021-01-01

Founders:

Alexander Hafez, Kosmas Karadimitriou, Nikolaos Mellios

Number of Employees:

11-50

Last Funding Date:

2024-01-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai